Jackie Fouse

Biography

Jacqualyn Fouse joined Dermavant as Executive Chairman in July 2017. Dr. Fouse previously served as President and Chief Operating Officer of Celgene Corporation until April 2017, and as a member of Celgene’s Board of Directors through June 2017. She joined Celgene in 2010 as Chief Financial Officer and was named president of the company’s global Hematology & Oncology franchise in 2014. Her experience at Celgene included working closely with the business unit that launched OTEZLA® for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis. Before joining Celgene, Dr. Fouse served as Chief Financial Officer of Bunge Limited, a leading global agribusiness and food company. Prior to Bunge, she served as Senior Vice President, Chief Financial Officer, and Head of Corporate Strategy at Alcon Laboratories, a leading ophthalmic pharmaceutical and medical device company. Prior to her tenure with Alcon, she held a variety of senior leadership roles with international companies, spending almost a decade of her career in Switzerland. Dr. Fouse earned her B.A. and M.A. in Economics and a Ph.D. in Finance from the University of Texas at Arlington.  

Research Interest

 Business Administration & Management